Literature DB >> 16546331

Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP).

Jennifer S Bennetts1, Lindsay F Fowles, Jennifer L Berkman, Kelly Lammerts van Bueren, Joy M Richman, Fiona Simpson, Carol Wicking.   

Abstract

Cdca4 (Hepp) was originally identified as a gene expressed specifically in hematopoietic progenitor cells as opposed to hematopoietic stem cells. More recently, it has been shown to stimulate p53 activity and also lead to p53-independent growth inhibition when overexpressed. We independently isolated the murine Cdca4 gene in a genomic expression-based screen for genes involved in mammalian craniofacial development, and show that Cdca4 is expressed in a spatio-temporally restricted pattern during mouse embryogenesis. In addition to expression in the facial primordia including the pharyngeal arches, Cdca4 is expressed in the developing limb buds, brain, spinal cord, dorsal root ganglia, teeth, eye and hair follicles. Along with a small number of proteins from a range of species, the predicted CDCA4 protein contains a novel SERTA motif in addition to cyclin A-binding and PHD bromodomain-binding regions of homology. While the function of the SERTA domain is unknown, proteins containing this domain have previously been linked to cell cycle progression and chromatin remodelling. Using in silico database mining we have extended the number of evolutionarily conserved orthologues of known SERTA domain proteins and identified an uncharacterised member of the SERTA domain family, SERTAD4, with orthologues to date in human, mouse, rat, dog, cow, Tetraodon and chicken. Immunolocalisation of transiently and stably transfected epitope-tagged CDCA4 protein in mammalian cells suggests that it resides predominantly in the nucleus throughout all stages of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546331     DOI: 10.1016/j.gene.2006.01.027

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.

Authors:  Matthew S Stratton; Rushita A Bagchi; Marina B Felisbino; Rachel A Hirsch; Harrison E Smith; Andrew S Riching; Blake Y Enyart; Keith A Koch; Maria A Cavasin; Michael Alexanian; Kunhua Song; Jun Qi; Madeleine E Lemieux; Deepak Srivastava; Maggie P Y Lam; Saptarsi M Haldar; Charles Y Lin; Timothy A McKinsey
Journal:  Circ Res       Date:  2019-08-14       Impact factor: 17.367

2.  Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP.

Authors:  Chengping Li; Samil Jung; Soonduck Lee; Dongjun Jeong; Young Yang; Keun-Il Kim; Jong-Seok Lim; Chung-Il Cheon; Changjin Kim; Young-Sook Kang; Myeong-Sok Lee
Journal:  Oncotarget       Date:  2015-04-10

3.  The drug target genes show higher evolutionary conservation than non-target genes.

Authors:  Wenhua Lv; Yongdeng Xu; Yiying Guo; Ziqi Yu; Guanglong Feng; Panpan Liu; Meiwei Luan; Hongjie Zhu; Guiyou Liu; Mingming Zhang; Hongchao Lv; Lian Duan; Zhenwei Shang; Jin Li; Yongshuai Jiang; Ruijie Zhang
Journal:  Oncotarget       Date:  2016-01-26

4.  Systems genetics in diversity outbred mice inform BMD GWAS and identify determinants of bone strength.

Authors:  Basel M Al-Barghouthi; Larry D Mesner; Gina M Calabrese; Daniel Brooks; Steven M Tommasini; Mary L Bouxsein; Mark C Horowitz; Clifford J Rosen; Kevin Nguyen; Samuel Haddox; Emily A Farber; Suna Onengut-Gumuscu; Daniel Pomp; Charles R Farber
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 17.694

5.  TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.

Authors:  Jit Kong Cheong; Lakshman Gunaratnam; Zhi Jiang Zang; Christopher M Yang; Xiaoming Sun; Susan L Nasr; Khe Guan Sim; Bee Keow Peh; Suhaimi Bin Abdul Rashid; Joseph V Bonventre; Manuel Salto-Tellez; Stephen I Hsu
Journal:  J Transl Med       Date:  2009-01-20       Impact factor: 5.531

6.  Identification of novel susceptibility loci for non-syndromic cleft lip with or without cleft palate.

Authors:  Lan Ma; Shu Lou; Ziyue Miao; Siyue Yao; Xin Yu; Shiyi Kan; Guirong Zhu; Fan Yang; Chi Zhang; Weibing Zhang; Meilin Wang; Lin Wang; Yongchu Pan
Journal:  J Cell Mol Med       Date:  2020-10-27       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.